Journal Selection Report
An Award-Winning Organization Committed to Supporting the ResearchCommunity across the World

Page 2 of 16*SAMPLE COPY*

Message from the Journal Selection ExpertThank you for choosing Enago to assist you in selecting suitable journals for publishing your paper. We havecarefully reviewed your manuscript and have shortlisted five journals that are best suited for it. The
selection and order of recommendation are based on a subjective opinion that takes into account the
specifics of your article and various relevant journal characteristics. We have provided a comparison of themost relevant journal characteristics that may aid the submission and publication process from the next
page onwards, along with my comments to help you improve your manuscript. We have also provided asummary for each journal. Please check all the details presented in the summary and visit the webpages of
the journals before making your decision.
Once you select a journal, you may also request our recommended services to help ensure that yoursubmission meets all the guidelines specified by the journal of your choice. Thank you again for choosing
Enago to help you!

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 3 of 16

Manuscript Details
Assignment Code:ABCDEF-1

Word Count:

4350

Journal Recommendations
The following journals have been shortlisted by our Journal Selection expert keeping in consideration author
preferences and paper’s research compliance by following a careful evaluation of your manuscript. The selection
and order of recommendation are based on a subjective opinion which takes into account the specifics of yourarticle and various relevant journal characteristics. Some of these characteristics, along with other information that
may aid the submission and publication process of the manuscript are listed below.

Overview of recommended Journals
Journalno:

Journal name

ImpactfactorPublisher

Issues per
year

Paid (P)/Unpaid (U)Recommendation
Level

BASED ON AUTHOR PREFERENCES + PAPER’S RESEARCH COMPLIANCE
1

Circulation Journal

2.540

J Stage

12

P

High

2

European Journal ofRadiology

2.687

Elsevier

12P

Moderate

3

American Journal of
Cardiology

2.570

Elsevier

12P

Moderate

BASED ON PAPER’S RESEARCH COMPLIANCE
1Journal of Cardiology

2.246

Elsevier

12

P

High

2

Cardiology

1.791

Karger

12

PModerate

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 4 of 16

Recommendation Level: High

[Based on author preferences + paper’s research compliance]

Journal name

Circulation Journal

Journal homepage URL

https://www.jstage.jst.go.jp/browse/circj/-char/en

Reason for choosing this journalThis journal is recommended as its scope specializes on reports about cardiology
which is highly appropriate to the authors’ study on the effects of β‒blocker
administration on cardiac function. Compared to the other recommended
journals, this journal has a reasonable impact factor. The title should appeal to
the readership of this journal in the area of cardiology. While there have been
similar studies published in this journal on cardiology, this particular research
focus area has not been addressed. The techniques used were sufficient and up
to date, and all ethical statements have been inserted. Given the nature of thestudy, this journal’s impact factor is moderate enough to give the paper a
considerable chance for publication.
Is the paper compatible with the Yes, as an Original Article.
journal guidelines
It appears the authors’ manuscript should be appropriate for a first submission.
The title page must have the following contents:(1) Complete title of the paper; Abbreviations are not acceptable in the title.
(2) Name(s) of author(s) with highest academic degree(s); Only MD, PhD, or BSc
should be included. Note that fellows of
the Japanese Circulation Society are supposed to add FJCS after their academic
degrees.
(3) Affiliations of all authors at the time of the study (i.e. department andinstitution).
(4) Short title; Up to 50 characters, including spaces, can be used.
(5) Disclosures; Information on all COI, grants, and sources of funding related tothe manuscript should be declared.
(6) IRB information; Name of the ethics committee and the reference number.
(7) Name and address of the author responsible for correspondence.
https://www.j-circ.or.jp/old/journal/files/Instructions_CJ.pdf

Journal Details
Impact factor

2.540

Specific topics covered

Circulation Journal has contributed to scientific progress in the field ofcardiovascular medicine.

Review type

Standard peer-review process. The articles will be accepted or rejected based on
their own merit.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 5 of 16
Approximate time for peer
review

17 days

Issues published per year

12

Accessibility

Open AccessFee for Open-Access, if
applicable$3000

Additional fee for color figure,if applicable

None stated

Databases where journal isindexed

BIOSIS, CAB Abstracts, Chemical Abstracts, Current Contents, EMBASE, and
MEDLINE

Publisher and country

J-Stage : Japan

ISSN code

1347-4820

Similar research articles
published by this journal

Noda T et al. Safety and efficacy of human muse cell-based product for acute
myocardial infarction in a first-in-human trial. Circ J. 2020 Jun 25;84(7):11891192. doi: 10.1253/circj.CJ-20-0307. Epub 2020 Jun 11.
Matsuzawa Y et al. In-hospital mortality in acute myocardial infarction according
to population density and primary angioplasty procedures volume. Circ J. 2020
Jun 25;84(7):1140-1146. doi: 10.1253/circj.CJ-19-0869. Epub 2020 May 27.

Recommendation Level: Moderate[Based on author preferences + paper’s research compliance]

Journal nameEuropean Journal of Radiology

Journal homepage URL

http://www.ejradiology.com/

Reason for choosing this journalThis journal was recommended as its scope specializes on all reports in radiology,
which is highly in line with the authors’ paper on the effects of β‒blocker
administration on cardiac function. This journal has an impact factor that ismoderate, which is acceptable for the authors’ study, and may ensure a more
rapid peer review process. The title should appeal to the readership of thisjournal in all fields of radiology and respiratory research. Although there havebeen similar studies published in this journal related to radiotherapy methods,
this particular subject matter has not been addressed. The techniques used were
sufficient and up to date. The authors described the ethical statements in detail.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 6 of 16

Is the paper compatible withjournal guidelines

The authors should describe future follow up studies that could confirm thefindings of this study in comparison to the closely related papers published in thisjournal.
No. As an Original Article.
The abstract should be un-structured.
Highlights
Highlights are mandatory for this journal. They consist of a short collection ofbullet points that convey the core findings of the article and should be submitted
in a separate editable file in the online submission system. Please use 'Highlights'
in the file name and include 3 to 5 bullet points (maximum 85 characters,
including spaces, per bullet point). You can view example of Highlights on thejournal’s information site.
https://www.ejradiology.com/content/authorinfo

Journal Details
Impact factor

2.687

Specific topics covered

European Journal of Radiology is an international journal which aims tocommunicate to its readers, state-of-the-art information on imaging
developments in the form of high quality original research articles and timely
reviews on current developments in the field.
Its audience includes clinicians at all levels of training including radiology
trainees, newly qualified imaging specialists and the experienced radiologist. Its
aim is to inform efficient, appropriate and evidence-based imaging practice tothe benefit of patients worldwide.
Standard peer-review process. The articles will be accepted or rejected based on
their own merit.

Review type

Approximate time for peer
review

NA

Issues published per year

12

Accessibility

Subscription based with open-access available at an additional costFee for Open-Access, if
applicable$3000

Additional fee for color figure,if applicable

No charge for online color figures

Databases where journal isindexed

BIOSIS, Elsevier BIOBASE, Current Contents/Current Contents Search, MEDLINE®,
EMBASE, Radiology Index, Science Citation Index, Sociedad Iberoamericana deInformacion Cientifica (SIIC) Data Bases, Scopus
Elsevier : UK

Publisher and country

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 7 of 16
ISSN code

0720-048X

Similar research articles
published by this journal

Qi RX, Shao J, Jiang JS, Ruan XW, Huang S, Zhang Q, Hu CH. Myocardial
extracellular volume fraction quantitation using cardiac dual-energy CT with late
iodine enhancement in patients with heart failure without coronary arterydisease: A single-center prospective study. Eur J Radiol. 2021 May 1;140:109743.
doi: 10.1016/j.ejrad.2021.109743. Epub ahead of print. PMID: 33971572.
Artzner C, Daubert M, Ehieli W, Kong D, Mammarappallil J, Nikolaou K, Boll DT,
Koweek L. Impact of computed tomography (CT)-derived fractional flow reserveon reader confidence for interpretation of coronary CT angiography. Eur J Radiol.
2018 Nov;108:242-248. doi: 10.1016/j.ejrad.2018.09.035. Epub 2018 Oct 3. PMID:
30396663.

Recommendation Level: Moderate[Based on author preferences + paper’s research compliance]

Journal name

The American Journal of Cardiology

Journal homepage URL

https://www.ajconline.org/

Reason for choosing this journalThis journal is recommended as its scope specializes on all reports in cardiology
research, which is highly in line with the authors’ study on the effects of β‒blocker administration on cardiac function. This journal has a higher impact
factor compared to the top recommended journal, which is however, in linewith the range acceptable for the authors’ manuscript. The title should appeal
to the readership of this journal in all fields of cardiac research. Although there
have been similar studies published in this journal, this particular research
approach has not been published yet.
No.
This manuscript should be submitted as an original article.
Title Page and Abstract
For the complete title page, include the full first or middle and last names of all
authors. List the current affiliations of all authors and link author names andaffiliations by “a,” “b,” “c,” etc., after the author names and before theaffiliation. Provide information about grant support if necessary, including thelocation (City/state/country). If work described is supported by a grant from a
pharmaceutical company, that fact should be stated on the title page. Add atthe bottom the phrase "Corresponding author" followed a telephone number,email address, and mailing address. Add a 2-to 6-word running head.
Limit the abstract to 250 words or a single page. List 2 to 4 key words for subject
indexing at the end of the abstract.
Highlights:
Highlights are optional yet highly encouraged for this journal, as they increase

Is the paper compatible with thejournal guidelines

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 8 of 16
the discoverability of your article via search engines. They consist of a shortcollection of bullet points that capture the novel results of your research as well
as new methods that were used during the study (if any). Please have a look at
the examples here: example Highlights.
Highlights should be submitted in a separate editable file in the online
submission system. Please use 'Highlights' in the file name and include 3 to 5
bullet points (maximum 85 characters, including spaces, per bullet point).
https://www.ajconline.org/content/authorinfo

Journal Details
Impact factor

2.570

Specific topics covered

The American Journal of Cardiology is an independent, scientific, peer-reviewed
journal of original articles that focus on the practical, clinical approach to thediagnosis and treatment of cardiovascular disease.
Standard peer-review process. The articles will be accepted or rejected based on
their own merit.

Review type

Approximate time for peer
review

4.6 weeks

Issues published per year

12

Accessibility

Subscription-based with open access options

Fee for Open-Access, if
applicable$2960

Additional fee for color figure,if applicableMust be paid by the author if requested in print. The journal will invoice the fullcost of color reprints.

Databases where journal isindexedPublisher and country

Abstracts in Internal Medicine, Annals of Behavioral Medicine Abstracts, BRS
Database, Biotechnology Research Abstracts, CIS, Current Contents, MEDLINE®,
Index to Scientific Reviews, EMBASE, Science Citation Index
Elsevier (USA)ISSN code

0002-9149

Similar research articles
published by this journal

Park J et al. Optimal dose and type of beta-blockers in patients with acutecoronary syndrome undergoing percutaneous coronary intervention. Am J
Cardiol. 2020 Dec 15;137:12-19. doi: 10.1016/j.amjcard.2020.09.044.
Wang S et al. Effect of beta-blocker use on exercise heart rate gradient andreclassification of mortality risk in patients referred for exercise testing. Am J
Cardiol. 2020 Sep 1;130:152-156. doi: 10.1016/j.amjcard.2020.06.023.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 9 of 16

Recommendation Level: High

[Based on paper’s research compliance]

Journal name

Journal of Cardiology

Journal homepage URL

http://www.journals.elsevier.com/journal-of-cardiology/

Reason for choosing this journalThis journal was recommended as the scope of this journal specializes on reports
involving cardiology research, which is highly in line with the authors’ study on
the effects of β‒blocker administration on cardiac function. This journal has an
impact factor similar to the other top recommended journals, which is in linewith what is acceptable for the authors’ study. The title should appeal to thereadership of this journal in all fields of cardiovascular research. Although there
have been similar studies published in this journal, this particular researchfindings have not been addressed by authors of published papers in it. The
techniques used were sufficient and up to date, however, the nature of thisstudy limits the overall significance for a wide audience. The authors should
describe future follow-up studies that could confirm the findings of this study.
Is the paper compatible with the No.
journal guidelines
This manuscript should be submitted as an original article.
Please reformat the abstract as follows. Abstract. Provide a structured
abstract of no more than 300 words, presenting essential data in 4
paragraphs introduced by separate headings in the following order:- Background - rationale for study- Methods - brief presentation of methods- Results - brief presentation of significant results- Conclusions - succinct statement of study or/and data interpretation- Acknowledgments. Acknowledgements should appear at the end of thearticle prior to funding, Disclosures and the References.
https://www.elsevier.com/journals/journal-of-cardiology/0914-5087/guide-forauthors

Journal Details
Impact factor

2.246

Specific topics covered

Topics covered include ischemic heart disease, cardiomyopathy, valvular heartdisease, vascular disease, hypertension, arrhythmia, congenital heart disease,pharmacological and non-pharmacological treatment, new diagnostic techniques,
and cardiovascular imaging.
Standard peer-review process. The articles will be accepted or rejected based on
their own merit.

Review type

Approximate time for peer
reviewNA

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 10 of 16
Issues published per year

12

Accessibility

Subscription based with open-access available at an additional cost.

Fee for Open-Access, if
applicable

The open access publication fee for this journal is USD 3000, excluding taxes.

Additional fee for color figure,if applicable

Any figure submitted in color will be published in color at no cost to the author.

Databases where journal isindexedMEDLINE®; EMBASE; PubMed; Scopus; Science Citation Index Expanded

Publisher and country

Elsevier : Japan

ISSN code

0914-5087

Similar research articles
published by this journal

Harada D et al. The impact of right ventricular dysfunction on the effectiveness ofbeta-blockers in heart failure with preserved ejection fraction. J Cardiol. 2020
Oct;76(4):325-334. doi: 10.1016/j.jjcc.2020.05.001. Epub 2020 May 28.
Onoue K et al. New treatment for myocardial diseases. J Cardiol. 2021
Jun;77(6):620-625. doi: 10.1016/j.jjcc.2020.10.016. Epub 2020 Nov 26.

Recommendation Level: Moderate[Based on paper’s research compliance]

Journal name

Cardiology

Journal homepage URL

http://www.karger.com/Journal/Home/223832

Reason for choosing this journalThis journal was recommended as the scope of this journal specializes on allreports in cardiology, which is highly in line with the authors’ study on the effectsof β‒blocker administration on cardiac function. This journal has an impact factor
similar to the top recommended journal, which is acceptable for the authors’
study, and the acceptance rate of this journal may ensure a more rapid peer
review process. The title should appeal to the readership of this journal in all
fields of cardiology. Although there have been similar studies published in thisjournal, this particular subject matter has not been addressed. The techniques
used were sufficient and up to date for readers to understand the next level ofresearch approach applicable to it.
Is the paper compatible with the No.
journal guidelines
This manuscript should be submitted as an original article.
The first page should contain a short and concise title plus a running head of no

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 11 of 16
more
than
80
characters.
Abbreviations
shouldbeavoided.
Below the title, list all the authors’ names as outlined in the article sample,
which can be downloaded under Article Types. Each listed author must have an
affiliation, which comprises the department, university, or organization and its
location, city, state/province (if applicable), and country.
Place the full postal address of the corresponding author at the bottom of thefirst page, including at least one telephone number and e-mail address.
It should be written in a clear and concise way and be structured using thefollowing
subheadings:
Introduction,
Methods,
Results,
andDiscussion/Conclusion. Abbreviations used in the main text may be introduced
and used. Use neither bibliographic references nor references to figures ortables in the Abstract.
https://www.karger.com/Journal/Guidelines/223832

Journal Details
Impact factor

1.791

Specific topics covered'Cardiology' features first reports on original clinical, preclinical and fundamental
research as well as 'Novel Insights from Clinical Experience' and topicalcomprehensive reviews in selected areas of cardiovascular disease. 'Editorial
Comments' provide a critical but positive evaluation of a recent article. Papers
not only describe but offer critical appraisals of new developments in noninvasive and invasive diagnostic methods and in pharmacologic, nutritional andmechanical/surgical therapies. Readers are thus kept informed of current
strategies in the prevention, recognition and treatment of heart disease. Special
sections in a variety of subspecialty areas reinforce the journal's value as acomplete record of recent progress for all cardiologists, internists, cardiac
surgeons, clinical physiologists, pharmacologists and professionals in other areasof medicine interested in current activity in cardiovascular diseases.
Standard peer-review process. The articles will be accepted or rejected based on
their own merit.

Review type

Approximate time for peer
review

NA

Issues published per year

12

Accessibility

Subscription-based with open-access options.

Fee for Open-Access, if
applicable

3530 USD

Additional fee for color figure,if applicable

Up to 6 color illustrations per page can be integrated within the text at
CHF 960.00

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 12 of 16
Databases where journal isindexedJournal Citation Reports, PubMed/MEDLINE, Biological Abstracts, Embase,
SCOPUS, SCI, SCI-E

Publisher and country

Karger : Netherlands

ISSN code

1421-9751

Similar research articles
published by this journal

Jones J et al. Importance and assessment of quality of life in symptomatic
permanent atrial fibrillation: Patient focus groups from the RATE-AF Trial.
Cardiology. 2020;145(10):666-675. doi: 10.1159/000511048. Epub 2020 Aug 28.
Zhao Y et al. Angiotensin II receptor type 1 antagonists modulate vascular smoothmuscle cell proliferation and migration via AMPK/mTOR. Cardiology.
2019;143(1):1-10. doi: 10.1159/000500038. Epub 2019 Jul 15.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 13 of 16

Specific comments of the Journal Expert
Our subject area expert also offers the following suggestions which may improve the manuscript and/or
expedite publication.
Are the various parts of thepaper (abstract, introductionetc.) suitably written?

The title is effectively concise and informative. The title will appeal to thereadership of the target journals. Additional information, including a shortrunning title may also be required on the title page in line with the target journal
guidelines. The authors’ highest degrees are not required for all journals. An
abstract while an appropriate length, may require some specific reformatting
depending on the target journal. The rationale/importance of reporting thistechnique should be highlighted in the abstract. The rationale and purpose
should be presented in the Introduction..

Are the motivation for the work The purpose and significance of the study are clearly stated. The rationale
and the significance of the results the study is adequately developed.
clearly explained?
Does the manuscript state thefindings appropriately?

ofYes, the findings are stated appropriately throughout.

Is the manuscript ready for
Depending on the journal selected, only minor stylistic changes would be
publication in its current state? If required prior to submission. The journal should be formatted in line with theno, what do the authors need to formatting requirements of the target journal.
work on?
Is the length compatible to all the Yes, the length of the manuscript is compatible with all journals.
suggested journals?

Are all the findings appropriately Yes, the findings are backed by high quality, relevant literature. The conclusions
stated and backed by substantial are well-supported by relevant literature. The authors may wish to include someevidence?
additional literature in support of their findings.
Is the research novel to this field? Yes, the authors present novel clinical data; however, there are some othersimilar studies that have been published in the field.
https://pubmed.ncbi.nlm.nih.gov/17587526/
https://pubmed.ncbi.nlm.nih.gov/27941018/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879696/
https://pubmed.ncbi.nlm.nih.gov/30654888/
The authors are encouraged to review these manuscripts carefully and tohighlight key differences in their study in order to increase the perceived
novelty.
Recommendations for improving - Format the paper according to the chosen journal guidelines.
the manuscript- Reformat citations and reference list as applicable.
- Reformat the abstract as required.
- English editing of the text is required to ensure the accuracy of language
and grammar.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 14 of 16

Current Manuscript Status and Recommendation
Your manuscript should be reviewed by expert reviewers to seek suggestions and constructive comments
before submission for publication.
Recommendation: See Pre-submission Review
Overall flow of the manuscript and writing style should be corrected before publication.
Recommendation: See Advance Editing

Thank you for choosing Enago as your Publication Support partner! We will be happy to address
any queries you may have related to this report. Please send us your detailed queries atpublish@enago.com

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 15 of 16

Frequently Asked Questions (FAQ)[Q1] I have received the Journal Selection Assistant (JSA)
report; how do I select a suitable journal from thesuggestions provided in the report?
[A] You can choose to go by the sequence in which thejournals are recommended either based on author
preferences or paper’s research compliance, while
understanding the reason for recommendation and thespecific topics the journal covers for publication. Theseshould be your primary selection criteria followed by otherelements like the Impact Factor, Compatibility, and Fees etc.
[Q2] Is the first journal mentioned in the JSA report a better
choice for my manuscript?
[A] All journals suggested in the JSA report are suitable foryour manuscript. However, you can opt for any of the firsttwo journals under “High” recommendation category inwhich the experts feel that your paper will have a higher
chance of publication. On the other hand, you may read thecomments of the expert for the journals under “Moderate”
recommendation category to understand their extent ofsuitability to your paper. Accordingly, you may choose to pick
any of the five journals for your manuscript.
[Q3] What is the difference between journals
recommended based on author preferences + paper’s
research compliance and paper’s research compliance?
[A] The journals recommended under author preferences +paper’s research compliance are the ones which are foundto be meeting most of your preferences as well as arecompliant with the paper’s research, based on the level ofrecommendation. However, the ones recommended underpaper’s research compliance might not meet yourpreferences, but were found to be most compliant with thepaper’s research, based on the level of recommendation.
[Q4] Which aspect of the journal guidelines should I referbefore selecting a suitable journal?
[A] Please refer to the required word count, article type, andlimitations on the number of references, tables and figures
allowed by the journals and compare them with your paper
to identify the best fit journal for your manuscript.
[Q5] What is the difference between paid and unpaid
journals mentioned as “P/U” in the table?
[A] If the journal charges any processing fees like article
processing charge (APC)/open access fee or publication fee
from the author, then we would consider this journal as a
“Paid journal (P)”. If the journal does not charge any fees

despite having an Open Access option or if it is a
subscription-based journal, then we would consider this as“Unpaid journal (U)”.
[Q6] What is the difference between single-blind, doubleblind and open peer-review process?
[A] Single-blind: Reviewers are aware of the author’s
identity, but authors do not know who reviewed theirmanuscript.
Double-blind: Authors and reviewers are unaware of eachother’s identify as the journal editor does not reveal thesedetails to either of them.
Open peer-review: Both the authors and reviewers areaware of each other’s identities.
[Q7] What does “Standard peer-review process” mean?
[A] Standard review refers to the process of reviewing thepaper at first by the journal editor. If the research falls within
the stringent scope of the journal, it is further reviewed in
depth by journal reviewers. When the journal webpage does
not mention the type of the peer-review process, it isgenerally considered as a standard peer-review process thatis similar to single-blinded review.
[Q8] How do I identify rapid publication journals?
[A] Generally, journals with a shorter peer-review time or
rapid editorial decision within 4-8 weeks are considered tohave a fast publication cycle. However, some journals may
respond with their first decision within 10-15 days. In case ofjournals that do not mention the peer review time, thenumber of issues published in a year can be considered todetermine its publication speed. Journals that publish 6 ormore issues in a year are usually rapid publication journals.
[Q9] What does “NA” mean in few sections of the JSA
report?
[A] NA means “Not Available”. This is usually written when
the information for a particular section in the report is notavailable on the journal webpage or any of the trusted
sources.
[Q10] Do I need to revise my manuscript based on thecomments provided in the JSA report?
[A] Yes, please refer to the section ‘Specific Comments of the
Journal Expert’ in order to understand the areas of
improvement in the manuscript. Revise the specific sectionsof your paper according to the suggestions, thereby
improving the quality of research.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of themanuscript and should not be considered as a guarantee of acceptance in any of the listed journals.

Page 19 of 16

Our Commitment
Enago recognizes the need to deliver high-quality services andguarantees the security of your information at all times. This belief isreflected in our commitment towards establishing and maintaining
systems and processes that are compliant with the ISO quality and IT
security management standards.

Our relationship with you does not end here. In fact, this is just the
beginning!

Enago is committed to helping you get your research published and we will ensure that your future needs are
met. For any assistance, simply mail us at publish@enago.com. Your dedicated assignment manager will behappy to help you with all your needs and queries.

Enago | Disclaimer: This report was compiled by our Journal Expert(s) after careful consideration of your manuscript considering several
parameters. The author(s) should read the report carefully to choose the target journal. This report is based on our expert’s assessment of
the manuscript and should not be considered as a guarantee of acceptance in any of the listed journals.